These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 991757)

  • 1. [Bleeding times in haemophilia patients treated with lyophilised antihaemophilic globulin (AHG) (author's transl)].
    Sutor AH; Jesdinsky-Buscher CJ
    Dtsch Med Wochenschr; 1976 Nov; 101(47):1715-9. PubMed ID: 991757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bleeding in haemophilia during massive treatment with anti-haemophilic globulin (author's transl)].
    Sutor AH; Jesdinsky-Buscher C
    Dtsch Med Wochenschr; 1975 May; 100(21):1183-6. PubMed ID: 1132328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of haemophilia with factor VIII inhibitor by giving isoagglutinin-free factor VIII concentrate (author's transl)].
    Bartholomé K; Geiger H; Schimpf K
    Dtsch Med Wochenschr; 1976 Aug; 101(34):1252-4. PubMed ID: 947734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Joint bleeding in haemophiliacs receiving substitution treatment as out-patients (author's transl)].
    Barthels M; Gerstel J
    Dtsch Med Wochenschr; 1975 Jul; 100(29):1523-9. PubMed ID: 1149632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
    Duckert F; Müller G; Meili EO
    Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of combined deficiency of factor IX and factor VIII with prolonged bleeding time (author's transl)].
    Kudo Y; Yokoyama M; Kimura A; Takamatsu H
    Rinsho Ketsueki; 1977 Jan; 18(1):81-7. PubMed ID: 300441
    [No Abstract]   [Full Text] [Related]  

  • 7. [A controlled study of treating haemophilia A on an out-patient basis (author's transl)].
    Schimpf K; Fischer B; Rothmann P
    Dtsch Med Wochenschr; 1976 Jan; 101(5):141-8. PubMed ID: 813984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Production of factor VIII preparations and their use in the substitution therapy of hemophilia A].
    Gaerisch F; Stein P
    Z Gesamte Inn Med; 1982 Oct; 37(19):641-4. PubMed ID: 6817530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylactic treatment of severe forms of hemophilia A with fraction I (AHG) and PAMBA].
    Gaerisch F; Mey U
    Bibl Haematol; 1967; 27():270-7. PubMed ID: 5302128
    [No Abstract]   [Full Text] [Related]  

  • 10. Concentrated preparations of Factor 8 (antihaemophilic globulin) in the management of haemophilia A and von Willebrand's disease.
    Castaldi PA; Somer JB; Schiff P; Blackburn CR
    Med J Aust; 1967 Sep; 2(11):481-5. PubMed ID: 5299300
    [No Abstract]   [Full Text] [Related]  

  • 11. [A clinical study of congenital factor XIII deficiency (author's transl)].
    Nakamura K; Itakura T; Yoshioka T; Suou T; Imai A
    Rinsho Ketsueki; 1977 May; 18(5):636-47. PubMed ID: 904084
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prophylactic replacement therapy in hemophilia. A case report (author's transl)].
    Mitterstieler G
    Padiatr Padol; 1976; 11(2-2):469-74. PubMed ID: 967509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting.
    Björkman S; Folkesson A; Berntorp E
    Haemophilia; 2007 Jan; 13(1):2-8. PubMed ID: 17212717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cryoprecipitate antihaemophilic factor for the treatment of haemophilia.
    Bloom AL; Emmanuel JH
    Q J Med; 1968 Apr; 37(146):291-302. PubMed ID: 5656159
    [No Abstract]   [Full Text] [Related]  

  • 15. A quantitative and humane tail bleeding assay for efficacy evaluation of antihaemophilic factors in haemophilia A mice.
    Molina ES; Fujita A; Sogayar MC; Demasi MA
    Haemophilia; 2014 Nov; 20(6):e392-8. PubMed ID: 24975823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyophilized cryoprecipitate for children with hemophilia A.
    Nuchprayoon I; Sahasittiwat S; Kittikalayawong A; Chantanakajornfung A
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S293-7. PubMed ID: 12188426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of urinary tract hemorrhage in a child with hemophilia A treated with cryoprecipitate AHG].
    Foltyn H; Wróbel I
    Pediatr Pol; 1969 Sep; 44(9):1155-7. PubMed ID: 5364502
    [No Abstract]   [Full Text] [Related]  

  • 18. A method for the production of AHG rich cryoprecipitates & their use in the management of bleeding episodes in haemophilia.
    Kwa SB; Chen YF
    Singapore Med J; 1968 Mar; 9(1):12-6. PubMed ID: 5659889
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiology, immunology, and methods for the detection of inhibitors in haemophilia (author's transl)].
    Ortega F; Martin Villar J; Magallon M
    Sangre (Barc); 1978; 23(5B):688-98. PubMed ID: 725713
    [No Abstract]   [Full Text] [Related]  

  • 20. [Emergency treatment of haemophilia A with factor VIII inhibitors using activated prothrombin complex concentrates (author's transl)].
    Rasche H; Bindewald H; Köhle W; Scheck R; Heinrich R; Seibert K
    Dtsch Med Wochenschr; 1977 Mar; 102(9):319-23. PubMed ID: 300053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.